Cannabis and driving;Cannabis et conduite automobile

Praxis

Volumn 90, Issue 34, 2001, Pages 1398-1407

  Ménétrey, Annick ^a   Augsburger, M ^a   Giroud, Ch ^a   Mangin, P ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

Cannabis; Driving under influence of drugs; Forensic investigations

Indexed keywords

CANNABINOID;

ADULT; ARTICLE; ATTENTION; BLOOD; CANNABIS ADDICTION; CANNABIS SMOKING; CAR DRIVING; CASE REPORT; DRUG EFFECT; HUMAN; LEGAL ASPECT; MALE; PSYCHOMOTOR PERFORMANCE; SWITZERLAND; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ADULT; ATTENTION; AUTOMOBILE DRIVING; CANNABINOIDS; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; PSYCHOMOTOR PERFORMANCE; SWITZERLAND;

EID: 0035940101     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Rapport sur le Cannabis de la Commission fédérale pour les questions liées aux drogues - CFLD. Secrétariat: Office fédéral de la santé publique, 3013 Berne, Septembre 1999.
2. Augsburger M.: Médicaments et drogues au volant: détection et dosage. Thèse de doctorat - chap. 2, 45-47, 51-53, 1999.
3. Rehm J.: Modes de consommation et répartition des drogues en Suisse. Drogues illégales en Suisse 1990-1993, Institut suisse de prévention de l'alcoolisme et autres toxicomanies, Lausanne. ISBN 2-88351-008-3,19-29, 1995.
4. Augsburger M., Rivier L.: Drugs and alcohol among suspected impaired drivers in Canton de Vaud (Switzerland). Forensic Science International, 85, 95-104, 1997. (Pubitemid 27089447)
5. Giroud C., Broillet A., Augsburger M., Bernhard W., Rivier L., Mangin P.:Bref historique de la culture récente du chanvre en Suisse et problèmes médico-légaux engendrés par cette culture, Schweizerische Rundschau für Medizin Praxis, 88(4):113-21, 1999.
6. Krüger H.-P., Löbmann R.: Auftreten und Risiken von Cannabis im Strassenverkehr. In Cannabis im Strassenverkehr, ed. Gustav Fischer, chap. 5, 51-71, 1998.
7. Ramaekers J. G., Robbe H. W. J., O'Hanlon J. F.: Marijuana, Alcohol and Actual Driving Performance. Human Psychopharmacology and Clinical Experiments, 15, 551-558, 2000.
8. Simpson H. M.: Epidemiology of road accidents involving marijuana. Alcohol, Drugs and Driving, Abstracts and Reviews, 2 (3-4), 15-3, 1986.
9. Smiley A.: Marijuana: On-Road and Driving-Simulator Studies. In The Health Effect of Cannabis, ed. Centre for Addiction and Mental Health, chap 5, 173-191, 1999.
10. Chesher G. B.: Cannabis and Road Safety: An Outline of the Research Studies to Examine the Effects of Cannabis on Driving Skills and on Actual Driving Performance. In Parliament of Victoria, ed. Road Safety Committee, 67-95, 1995.
11. Rivier L., Staub C., Giroud C.: Caractérisation de la prise d'opiacés (héroïne, morphine, codéine et éthylmorphine) par l'intermédiaire de l'analyse d'urine: quels critères adopter?, Schweizerische Rundschau für Medizin Praxis, 80(42):1135-1139, 1991.
12. Giroud C., Colassis T., Rivier L., Ottinger E.: Cocaïne et alcool: un cocktail explosif!, Schweizerische Rundschau für Medizin Praxis, 82(15):441-446, 1993.
13. Giroud C., Augsburger M., Sadeghipour F., Varesio E., Veuthey J.-L., Rivier L.: Ecstasy - la situation en Suisse romande, Schweizerische Rundschau für Medizin Praxis, 86:511-523, 1997.
14. Gaoni Y., Mechoulam R.: Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc., 86, 1646-1647, 1964.
15. Herkenham M., Lynn A. B., Little M. D., Johnson M. R., Melvin L. S., De Costa B. R., Rice K. C.: Cannabinoid receptor localisation in brain. Proc. Nat. Acad. Sci. USA, 87, 1932-1936, 1990.
16. Munro S., Thomas K. L., Abu-shaar M.: Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65, 1993. (Pubitemid 23305569)
17. Glass M., Felder C. C.: Endogenous and Synthetic Cannabinoids and Their Receptors. Neurotransmissions, 14(3), 3-11, 1998.
18. Felder C. C., Glass M.: Cannabinoid Receptors and Their Endogenous Agonists. Annu. Rev. Pharmacol. Toxicol., 38, 179-200, 1998. (Pubitemid 28231493)
19. Ameri A.: The Effects of Cannabinoids on the Brain. Progress in Neurobiology, 58, 315-348, 1999.
20. Lichtman A. H., Martin B. R.: D9-Tetrahydrocannabinol Impairs Spatial Memory Through a Cannabinoid Receptor Mechanism. Psychopharmacology, 126, 125-131, 1996. (Pubitemid 26246762)
21. Miller L. L., Branconnier R. J.: Cannabis: Effects on Memory and the Cholinergic Limbic System. Psychological Bulletin, 93, 441-456, 1983.
22. Hollister L. E.: Health Aspects of Cannabis. Pharmacological Reviews, 38, 1-20, 1986
23. Solowij N.: Cannabis the drug. In Cannabis and Cognitive Functioning, ed. Addictions, Cambridge University Press, chap 2, 13-39, 1999.
24. Ashton C. H.: Adverse effects of cannabis and cannabinoids. British Journal of Anaesthesia, 83(4), 637-649, 1999.
25. Martin B. R., Cone E. J.: Chemistry and Pharmacology of Cannabis. In The Health Effect of Cannabis, ed. Centre for Addiction and Mental Health, chap. 2, 21-28, 1999.
26. Heishman S. J., Huestis M. A., Henningfield J. E., Cone E. J.: Acute and Residual Effects of Marijuana: Profiles of Plasma THC Levels, Physiological, Subjective, and Performance Measures. Pharmacology Biochemistry and Behavior, 37(3), 561-565, 1990.
27. Huestis M. A., Henningfield J. E., Cone E. J.: Blood Cannabinoids. I. Absorption of THC and Formation of 11-OH-THC and THCCOOH During and After Smoking Marijuana. Pharmacology Biochemistry and Behaviour, 16, 276-282, 1992.
28. Mechoulam R., Ben-Shabat S.: From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis. Nat. Prod. Rep., 16, 131-143, 1999. (Pubitemid 29207717)
29. Johansson E., Halldin M. M., Agurell S., Hollister L. E. and Gillespie H. K.: Terminal elimination plasma half-life of delta1-tetrahydrocannabinol (delta1-THC) in heavy users of marijuana. Eur. J. Clin. Pharmacol., 37, 273-277, 1989. (Pubitemid 19242734)
30. Berghaus G., Schulz E., Szegedi A.: Cannabis und Fahrtüchtigkeit. Ergebnisse des experimentellen Forschung. In Cannabis im Strassenverkehr, ed. Gustav Fischer, chap. 6, 73-97, 1998.
31. Heishman S. J., Arasteh K., Stitzer M. L.: Comparative Effects of Alcohol and Marijuana on Mood, Memory, and Performance. Pharmacology Biochemistry and Behaviour, 58(1), 93-101, 1997. (Pubitemid 27334358)
32. Robbe H. W. J.: Influence of Marijuana on Driving. Thesis Maastricht, chap. 3, 52-66, 1994.
33. Moskowitz H.: Marihuana and Driving. Accid. Anal. and Prev., 17(4), 323-345, 1985.
34. Smiley A.: Marijuana: On-Road and Driving-Simulator Studies. Alcohol, Drugs and Driving, 2, 121-134, 1987.
35. Ellingstad V. S., McFarling L. H., Struckman D. L.: Alcohol, marijuana and risk taking. Vermillion Human Factors Laboratory, South Dakota University, 1973.
36. Robbe H. W. J.: Marijuana's Impairing Effects on Driving are Moderate When Taken Alone But Severe When Combined with Alcohol. Hum. psychopharmacol. Clin. Exp., 13, S70-S78, 1998.
37. Hall W., Solowij N.: Adverse Effects of Cannabis. The Lancet, 352, 1611-1616, 1998. (Pubitemid 28515256)
38. Roques B.: Le Cannabis. Dans La dangerosité des drogues. Rapport au secrétariat d'État à la santé, ed. Odile Jacob, chap. 10, 177-216, 1999.
39. Smiley A. M., Moskowitz H., Ziedman K.: Driving simulator studies of marijuana alone and in combination with alcohol. American Association for Automotive Medicine Proceedings, October 1-3, 1981, San Francisco, 107-116, 1981.
40. Chesher G. B.: The Effects of Alcohol and Marijuana in Combination: a Review. Alcohol, Drugs, and Driving, 2(3-4), 105-119, 1986.
41. Perez-Reyes M., Hicks R. E., Bumberry J., Jeffcoat A. R., Cook C. E.: Interaction between Marihuana and Ethanol: Effects on Psychomotor Performance. Alcoholism: Clinical and Experimental Research, 12(2), 268-276, 1988.
42. Peck R. C., Biasotti A., Boland P. N., Mallory C., Reeve V.: The Effects of Marijuana and Alcohol on Actual Driving Performance. Alcohol, Drugs and Driving, 2(3-4), 135-154, 1986.
43. Kurzthaler I., Hummer M., Miller C., Sperner-Unterweger B., Günther V., Wechdorn H., Battista H.-J., Fleishhacker W. W.: Effect of Cannabis Use on Cognitive Functions and Driving Ability. J. Clin. Psychiatry, 60, 395-399, 1999.
44. Hauri-Bionda R., Friedrich-Koch A.: MEDRALEX für Polizeibeamte, Eine moderne Strategie zum Erkennen von Fahrunfähigkeit, Institut für Rechtsmedizin, Universität Zürich, ISBN: 3-9520617-3-5, Zürich 1998.
45. Hauri-Bionda R., Friedrich-Koch A., Hermann P. W.: MEDRALEX für Ärtze, Eine moderne Strategie zum medizinischen Nachweis von Fahrunfähigkeit, Institut für Rechtsmedizin, Universität Zürich, ISBN: 3-9520617-4-3, Zürich 1998.
46. Huestis M. A., Henningfield J. E., Cone E. J.: Blood Cannabinoids. II. Models for the Prediction of Time of Marijuana Exposure from Plasma Concentrations of D9-Tetrahydrocannabinol (THC) and 11-nor-9-carboxy-D9- tetrahydrocannabinol (THCCOOH). J. Anal. Toxicol., 16, 283-290, 1992.
47. Daldrup T.: Cannabis im Strassenverkehr. Abschlussbericht des im Auftrage des Ministeriums für Wirtschaft und Mittelstand Technologie und Verkehr des Landes Nordrhein-Westfalen durchgeführten Untersuchungsvorhabens, 44-59, 1996.
48. Rapport de l'académie des sciences: Aspects moléculaires, cellulaires et physiologiques des effets du cannabis. Académie des sciences, Institut de France, rapport n° 39, 23-31, 36-39, 1997.
49. Circulation routière et drogues. Séminaire organisé par le Groupe de coopération en matière de lutte contre l'abus et le trafic illicite de stupéfiants (Groupe Pompidou). Strasbourg, 19-21 avril 1999, ed. du Conseil de l'Europe, F-67075 Strasbourg Cedex, ISBN 92-871-4144-4, décembre 1999.